The staggering figure - which was revealed in a series of Freedom of Information (FOI) requests to the Department - shows the true cost of ongoing inaction related to the disease, which continues to ...
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva ; SELARSDI is expecte ...
For decades, measles was a rarely seen disease in the U.S., but now it's back on the rise, and the U.S. is at risk of losing ...
The latest CDC data show that chlamydia, hepatitis C, and syphilis are skyrocketing in Americans aged 55 and up. Separately, the WHO is warning about rising deaths from viral hepatitis. Also in the ...
Tuberculosis ... s deadliest infectious disease. A new report from the Centers for Disease Control and Prevention shows that cases of TB, a bacterial infection, once again rose in the U.S. in ...
NEW YORK (AP) — The number of U.S. tuberculosis cases in 2023 ... but have been rising since. Most U.S. TB cases are diagnosed in people born in other countries. Experts say the 2023 number ...
NEW YORK (AP) — The number of U.S. tuberculosis cases in 2023 ... but have been rising since. Most U.S. TB cases are diagnosed in people born in other countries. Experts say the 2023 number ...
The number of U.S. tuberculosis cases in 2023 was the highest in a decade, the Centers for Disease Control and Prevention has announced. The CDC said on its website Thursday that "overall ...
The number of U.S. tuberculosis cases in 2023 was the highest in a decade, according to a new government report. Forty states reported an increase in TB, and rates were up among all age groups ...
The number of U.S. tuberculosis cases in 2023 was the highest in ... Cases declined sharply at the beginning of the COVID-19 ...
Tuberculosis (TB) rates in the U.S. rose by 16 percent in 2023, marking the third year that cases went up following nearly 30 years of decline. In the most recent Morbidity and Mortality Weekly ...